Testicular Cancer

News alerts, weekly reports and conference planners

Related cancers:

‹

Testicular Seminoma (7)

›

No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	etoposide IV Sensitive: A1 - Approval etoposide IV Sensitive : A1	etoposide IV Sensitive: A1 - Approval etoposide IV Sensitive : A1
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	cisplatin Sensitive: A1 - Approval cisplatin Sensitive : A1	cisplatin Sensitive: A1 - Approval cisplatin Sensitive : A1
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1	ifosfamide Sensitive: A1 - Approval ifosfamide Sensitive : A1
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	TI-CE Sensitive: A2 - Guideline TI-CE Sensitive : A2	TI-CE Sensitive: A2 - Guideline TI-CE Sensitive : A2
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	EP Sensitive: A2 - Guideline EP Sensitive : A2	EP Sensitive: A2 - Guideline EP Sensitive : A2
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	VeIP Sensitive: A2 - Guideline VeIP Sensitive : A2	VeIP Sensitive: A2 - Guideline VeIP Sensitive : A2
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	BEP Sensitive: A2 - Guideline BEP Sensitive : A2	BEP Sensitive: A2 - Guideline BEP Sensitive : A2
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2
No biomarker	Testicular Seminoma	No biomarker	Testicular Seminoma	VIP Sensitive: A2 - Guideline VIP Sensitive : A2	VIP Sensitive: A2 - Guideline VIP Sensitive : A2
TMB-H	Testicular Seminoma	TMB-H	Testicular Seminoma	TIP Sensitive: A2 - Guideline TIP Sensitive : A2	TIP Sensitive: A2 - Guideline TIP Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	paclitaxel + gemcitabine Sensitive: A2 - Guideline paclitaxel + gemcitabine Sensitive : A2	paclitaxel + gemcitabine Sensitive: A2 - Guideline paclitaxel + gemcitabine Sensitive : A2
MSI-H/dMMR	Testicular Cancer	MSI-H/dMMR	Testicular Cancer	cemiplimab Sensitive: A2 - Guideline cemiplimab Sensitive : A2	cemiplimab Sensitive: A2 - Guideline cemiplimab Sensitive : A2
TMB-H	Testicular Cancer	TMB-H	Testicular Cancer	pembrolizumab Sensitive: A2 - Guideline pembrolizumab Sensitive : A2	pembrolizumab Sensitive: A2 - Guideline pembrolizumab Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	GemOx Sensitive: A2 - Guideline GemOx Sensitive : A2	GemOx Sensitive: A2 - Guideline GemOx Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	TI-CE Sensitive: A2 - Guideline TI-CE Sensitive : A2	TI-CE Sensitive: A2 - Guideline TI-CE Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2	carboplatin + etoposide IV Sensitive: A2 - Guideline carboplatin + etoposide IV Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	GemPOx Sensitive: A2 - Guideline GemPOx Sensitive : A2	GemPOx Sensitive: A2 - Guideline GemPOx Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	BNT211 Sensitive: B - Late Trials BNT211 Sensitive : B	BNT211 Sensitive: B - Late Trials BNT211 Sensitive : B
CHEK2 mutation	Testicular Cancer	CHEK2 mutation	Testicular Cancer	talazoparib Sensitive: C4 – Case Studies talazoparib Sensitive : C4	talazoparib Sensitive: C4 – Case Studies talazoparib Sensitive : C4

Testicular Cancer

Associations(20)

Associations
(20)